ERMAEnorama Pharma AB (publ)
0.2880SEK-0.35%Mkt Cap: 21.33M SEKP/E: Last update: 2026-05-13

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incor…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)
PEG
P/B-0.91
P/S7.79
EV/EBITDA-0.29
EV/Revenue6.68
EPS (TTM)-1.01
EPS (Forward)
Cash Flow & Leverage
FCF Yield-70.15%
FCF Margin-546.33%
Operating CF-59.26M SEK
CapEx (TTM)
Net Debt/EBITDA0.05
Net Debt-3.04M SEK
Technical
SMA 500.3816 (-24.5%)
SMA 2001.746 (-83.5%)
Beta1.60
S&P 52W Chg24.23%
Avg Vol (30d)24.74K
Avg Vol (10d)22.17K
Technical Indicators
RSI (14)41.3
MACD-0.0441
MACD Signal-0.0572
MACD Hist.+0.0131
BB Upper0.3242 SEK
BB Middle0.2871 SEK
BB Lower0.2500 SEK
BB Width25.82%
ATR (14)0.0449 SEK
Vol Ratio (20d)0.61x
52W Range
0.21102% of range3.580
52W High3.580 SEK
52W Low0.2110 SEK
Profitability
Gross Margin-549.22%
EBITDA Margin0.00%
Profit Margin-2743.30%
Oper. Margin-1055.17%
ROE320.41%
ROA-909.45%
Revenue Growth-33.70%
Earnings Growth
Balance Sheet
Debt/Equity0.00
Current Ratio0.25
Quick Ratio0.17
Book Value/Sh-0.3140 SEK
Cash/Share0.0410 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Ownership
Shares Out.74.59M
Float15.81M
Insiders93.57%
Institutions0.02%
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Company
Market Cap21.33M SEK
Enterprise Value18.30M SEK
Revenue (TTM)2.74M SEK
Gross Profit-15.04M SEK
Net Income (TTM)-75.14M SEK
Revenue/Share0.0390 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
Last Price0.2880 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN